Cargando…
Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members With Type 2 Diabetes
OBJECTIVES: Glycosylated hemoglobin (A1c) is a well-established measure of glycemic control, and evidence suggests that maintaining an acceptable A1c level may be associated with lower treatment costs in adults with diabetes. Understanding the impact on total treatment costs of staying at the target...
Autores principales: | Shetty, Sharashchandra, Secnik, Kristina, Oglesby, Alan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437578/ https://www.ncbi.nlm.nih.gov/pubmed/16137213 http://dx.doi.org/10.18553/jmcp.2005.11.7.559 |
Ejemplares similares
-
The association between diabetes related medical costs and glycemic control: A retrospective analysis
por: Oglesby, Alan K, et al.
Publicado: (2006) -
Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain
por: Yurgin, Nicole Rae, et al.
Publicado: (2008) -
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
por: Secnik Boye, Kristina, et al.
Publicado: (2006) -
Relationship Between Glycemic Control and Diabetes-Related Hospital Costs in Patients with Type 1 or Type 2 Diabetes Mellitus
por: Menzin, Joseph, et al.
Publicado: (2010) -
Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001
por: Johnson, Jeffrey A, et al.
Publicado: (2006)